Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 1
2005 4
2006 3
2007 1
2008 1
2009 3
2010 3
2011 2
2012 2
2013 1
2014 1
2015 3
2016 2
2017 3
2018 2
2019 3
2020 4
2021 7
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

45 results
Results by year
Filters applied: . Clear all
Page 1
Lipocalin-2 counteracts metabolic dysregulation in obesity and diabetes.
Mosialou I, Shikhel S, Luo N, Petropoulou PI, Panitsas K, Bisikirska B, Rothman NJ, Tenta R, Cariou B, Wargny M, Sornay-Rendu E, Nickolas T, Rubin M, Confavreux CB, Kousteni S. Mosialou I, et al. Among authors: tenta r. J Exp Med. 2020 Oct 5;217(10):e20191261. doi: 10.1084/jem.20191261. J Exp Med. 2020. PMID: 32639539 Free PMC article.
Hormonal responses following eccentric exercise in humans.
Philippou A, Maridaki M, Tenta R, Koutsilieris M. Philippou A, et al. Among authors: tenta r. Hormones (Athens). 2017 Oct;16(4):405-413. doi: 10.14310/horm.2002.1761. Hormones (Athens). 2017. PMID: 29518761 Free article.
Combination therapy using LHRH and somatostatin analogues plus dexamethasone in androgen ablation refractory prostate cancer patients with bone involvement: a bench to bedside approach.
Koutsilieris M, Bogdanos J, Milathianakis C, Dimopoulos P, Dimopoulos T, Karamanolakis D, Halapas A, Tenta R, Katopodis H, Papageorgiou E, Pitulis N, Pissimissis N, Lembessis P, Sourla A. Koutsilieris M, et al. Among authors: tenta r. Expert Opin Investig Drugs. 2006 Jul;15(7):795-804. doi: 10.1517/13543784.15.7.795. Expert Opin Investig Drugs. 2006. PMID: 16787142 Review.
The discovery of new cytotoxic pyrazolopyridine derivatives.
Giannouli V, Lougiakis N, Kostakis IK, Pouli N, Marakos P, Skaltsounis AL, Nam S, Jove R, Horne D, Tenta R, Pratsinis H, Kletsas D. Giannouli V, et al. Among authors: tenta r. Bioorg Med Chem Lett. 2016 Nov 1;26(21):5229-5233. doi: 10.1016/j.bmcl.2016.09.056. Epub 2016 Sep 24. Bioorg Med Chem Lett. 2016. PMID: 27720292
Levosimendan prevents doxorubicin-induced cardiotoxicity in time- and dose-dependent manner: implications for inotropy.
Efentakis P, Varela A, Chavdoula E, Sigala F, Sanoudou D, Tenta R, Gioti K, Kostomitsopoulos N, Papapetropoulos A, Tasouli A, Farmakis D, Davos CH, Klinakis A, Suter T, Cokkinos DV, Iliodromitis EK, Wenzel P, Andreadou I. Efentakis P, et al. Among authors: tenta r. Cardiovasc Res. 2020 Mar 1;116(3):576-591. doi: 10.1093/cvr/cvz163. Cardiovasc Res. 2020. PMID: 31228183
45 results